For thoracic surgeons, surgical instruments are one of the keys to the smooth implementation and promotion of single-port thoracoscopic surgery. Conventional thoracic surgical instruments are unable to meet the requirements of single-port thoracoscopic surgery, and the establishment of the thoracoscopic surgical system has put forward an urgent need for the research and development of specialized single-port thoracoscopic surgical instruments. The establishment of thoracoscopic surgery system has put forward an urgent demand for the development of specialized single-port thoracoscopic surgical instruments. The requirements of minimally invasive thoracic surgery operation mainly include the pulling of lung tissue, the freeing of pulmonary artery and pulmonary vein, and the freeing of bronchus and segmental bronchus. Under the condition of single-port thoracoscopy, due to the limited angle, for surgical instruments, there is a special requirement for surgical instruments, which need to be more delicate, more flexible, and at a better angle, so in order to meet the clinical needs, the Department of Thoracic Surgery of Shanghai Pulmonary Hospital carries out the efforts and promotion in this area.

The Department of Thoracic Surgery in our hospital continuously studies and strives for perfection in the aspects of single-hole thoracoscopic surgery. After summarizing the shortcomings of traditional thoracoscopic surgical instruments, combined with the design concept of mechanics and biomechanics, and improved and shaped through continuous clinical trials, we designed and completed the single-hole thoracoscopic instrument set firstly patented by the pulmonary hospital in China. This set of instruments is also the first international single-hole thoracoscopic surgical instruments. Scanlan, the world's top brand of surgical instruments, has taken the initiative to seek cooperation on patent transformation, named it "SPH (Shanghai Pulmonology)", and promoted it globally (the only one in China's surgical field): the set of instruments are all independently developed by the Department of Thoracic Surgery of the hospital and the application for utility model patent has been completed, and the set of instruments has already been applied in the clinic after transformation of patent. This set of instruments has been applied in clinical practice after patent transformation, and has been well received by surgeons.

The complete set of single-port thoracoscopic surgical instruments mainly includes: double-jointed snakehead biopsy forceps (two sizes), double-jointed lung forceps, double-jointed non-invasive vascular forceps, and thoracoscopic wire holder. This set of instruments for single-port thoracoscopic surgery has the following advantages: it occupies less space during surgery, reduces the collision between surgical instruments, and allows the single-port incision to accommodate more instruments, which facilitates the operator's operation and improves surgical efficiency. Adhering to the principles of maximizing the efficiency of use, maximizing the safety of tissue handling, and maximizing the reliability of completing surgical technique movements, the set was finalized and produced after many improvements, and its performance is superior in terms of exposing the surgical field, avoiding the interference of instruments, and facilitating the safety of excursion. Overall, this set of instruments effectively improves the maneuverability of the instruments and enhances the efficiency and safety of surgery.

This series of instruments has won awards in the past 3 years, and won the first prize and innovation star of the "Starlight Program" of Shanghai medical workers' scientific and technological innovation in 2017, the silver prize of Shanghai excellent invention in 2018, and the gold prize of Shanghai workers' technological innovation achievements in 2019. Patent transformation to the market. Applied to hundreds of hospitals across the country, the domestic market share in the last five years domestic first. Of course, in addition to the patent into a product with economic benefits, but also play a convenient doctor and benefit the patients of great significance.

Meanwhile, Scanlan, the world's top surgical instrument manufacturer, took the initiative to seek cooperation on patent conversion, named it as "SPH (Shanghai Pulmonary Hospital)" and promoted it globally (the only one in the domestic and international scientific circles), and it has been ranked the No. 1 in sales of surgical instruments in the field of thoracic surgery for 2 consecutive years in the international arena. No.1 in sales of surgical instruments in the field of thoracic surgery for 2 consecutive years now in the international arena.

Double-jointed Snakehead Biopsy Forceps (Patent No.: ZL201420453938.4),

Double-jointed Lung Forceps (Patent No.: ZL201420786464.5)

Thoracoscopic Lung Retractor Forceps (Patent No.: ZL201410013717.X)

Thoracoscopic Curvilinear Card (Patent No.: ZL201721909576.5)

Thoracoscopic Wire Holder (Authorization No.: ZL2012205209576.5)

Thoracoscopic Wire Holder (Patent No.: ZL2012205209576.5). No.: ZL201220514102.1)

Thoracoscopic Surgical Knotter (Patent No.: ZL201420802460.1, ZL201420802457.X)

Dual-jointed Lung Fracture Forceps (Patent No.: ZL201620538438.X)

Improved Needle Holder (Patent No.: ZL201520458447.3)